Healthcare -
Biotechnology - NASDAQ - US
$ 4.815
-0.926 %
$ 273 M
Market Cap
-5.66
P/E
Price Target
Average
291.14%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
26.53%
Net Income
Estimate
--8.73%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Design Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for DSGN of $18.8 , with forecasts ranging from
a
low of
$7 to a high of $42 .
DSGN Lowest Price Target
Wall Street Target
7 USD
45.38%
DSGN Average Price Target
Wall Street Target
18.8 USD
291.14%
DSGN Highest Price Target
Wall Street Target
42 USD
772.27%
REVENUE FORECAST
Revenue Forecast Chart DSGN
EBIT FORECAST
EBIT Forecast Chart DSGN
NET INCOME FORECAST
Net Income Chart DSGN